Author: Nathan Goldstein In recent years, the life sciences industry has been drastically impacted by regulatory pressures, complex global networks, and rising production costs. This has forced supply chain leaders to develop aggressive business models that meet both regulatory and market demands while ensuring resilience across all components of their